4//SEC Filing
McHugh Miles W 4
Accession 0001209191-21-067914
CIK 0001492426other
Filed
Dec 2, 7:00 PM ET
Accepted
Dec 3, 5:20 PM ET
Size
9.2 KB
Accession
0001209191-21-067914
Insider Transaction Report
Form 4
McHugh Miles W
Sr VP & Princ. Acctg Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2021-12-01−79,484→ 0 totalExercise: $22.14Exp: 2025-03-22→ Ordinary shares (79,484 underlying) - Exercise/Conversion
Ordinary Shares
2021-12-01$22.14/sh+79,484$1,759,776→ 116,005 total - Sale
Ordinary Shares
2021-12-01$106.62/sh−79,484$8,474,584→ 36,521 total
Footnotes (2)
- [F1]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.00 to $106.65 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]The option is fully vested and exercisable.
Documents
Issuer
Horizon Therapeutics Public Ltd Co
CIK 0001492426
Entity typeother
Related Parties
1- filerCIK 0001366227
Filing Metadata
- Form type
- 4
- Filed
- Dec 2, 7:00 PM ET
- Accepted
- Dec 3, 5:20 PM ET
- Size
- 9.2 KB